---

---

tags : Trial    crawled date : 2021 - 10 - 07   

save search

---

Industrial Food Cutting Machines Market to Register USD 84.02 Mn| Rising number of product launches Boost Market Growth | Technavio
Published: 2021-10-07 (Crawled : 23:00) - prnewswire.com
ITW | News | $250.46 0.66% 0.0% 2.1M |

Producer Manufacturing

| 16.41% | O: -0.33% H: 0.0% C: 0.0%
food growth trial

---

Repare Therapeutics Issues Statement Regarding Inadvertent Issuance of Phase 1/2 TRESR RP-3500 Clinical Trial Abstract by the AACR-NCI-EORTC Virtual International Conference
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
RPTX 4 | $3.14 3.97% 3.82% 220K |

Health Technology

| -87.89% | O: -0.32% H: 0.28% C: -11.87%
phase 1 trial conference

---

Industrial Adhesives Market Will Grow by USD 16.98 | Featuring 3M Co., Arkema SA, Ashland Global Holdings Inc. Among Key Players | Technavio
Published: 2021-10-07 (Crawled : 23:00) - prnewswire.com
ASH | News | $95.99 0.52% 0.0% 410K |

Process Industries

| 1.31% | O: -0.03% H: 0.54% C: -0.32%
trial

---

BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
BCDA | $0.377 -1.4% 97K |

Health Technology

| -86.38% | O: 2.15% H: 8.07% C: 4.21%
heart therapy trial cardiamp

---

GeneTx and Ultragenyx Announce First Patient Dosed in Canada in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
RARE F | $42.37 -2.33% -2.38% 680K |

Health Technology

| -49.0% | O: -0.63% H: 2.87% C: -0.58%
phase 1 trial syndros

---

Industrial Overrunning Clutches Market Size Grows by USD 28.77 Bn | 51% Growth to Originate in APAC | Technavio
Published: 2021-10-07 (Crawled : 22:00) - prnewswire.com
AIMC | $61.98 -0.02% 0.0% 0 |

Producer Manufacturing

| 12.83% | O: 0.44% H: 0.0% C: 0.0%
growth trial

---

Allogene Therapeutics Reports FDA Clinical Hold of AlloCAR T Trials Based on a Single Patient Case in ALPHA2 Trial
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
ALLO | $3.48 0.58% 0.57% 2M |

Health Technology

| -85.4% | O: 0.42% H: 3.86% C: 1.29%
fda trials trial clinical hold

---

Bicycle Therapeutics Announces Interim BT5528 Phase I Clinical Trial Results and Preliminary Results from Ongoing BT8009 Phase I Clinical Trial
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
BCYC | $23.41 -4.41% -4.61% 550K |

Health Technology

| -47.41% | O: -1.13% H: 21.05% C: 18.09%
ongoing results trial trial results

---

Axalta expands Imron® Industrial portfolio with a new high-performance urethane DTM primer
Published: 2021-10-07 (Crawled : 14:15) - prnewswire.com
AXTA | $30.87 -2.96% 0.0% 4.9M |

Process Industries

| 8.12% | O: 0.99% H: 2.95% C: 2.21%
trial primec

---

Industrial Enzymes Market Size to Reach USD 8400.4 Million by 2027 at a CAGR of 4.9% | Valuates Reports
Published: 2021-10-07 (Crawled : 13:15) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
trial

---

Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Published: 2021-10-07 (Crawled : 13:15) - biospace.com/
AVGR | $4.02 2.55% 2.49% 5.6K |

Health Technology

| 422.67% | O: 20.26% H: 1.81% C: -6.35%
trial presentation

---

ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC
Published: 2021-10-07 (Crawled : 13:15) - biospace.com/
ORIC | $9.2 -3.26% -3.37% 670K |

Health Technology

| -48.69% | O: -6.68% H: 0.42% C: -30.82%
phase 1 trial phase 1b preclinical pre-clinical phase 2b

---

Acumen Announces First Patient Dosed in a Phase 1 Clinical Trial of ACU193, a Monoclonal Antibody that Selectively Targets Toxic Aβ Oligomers for the Treatment of Early Alzheimer’s Disease
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
ABOS | $3.14 -0.63% -0.64% 310K |

Professional, Scientific, and T...

| -76.63% | O: 0.81% H: 0.0% C: -1.14%
disease alzheimer treatment phase 1 antibody trial aβos alzheimer’s alzheimer's disease alzheimer's

---

Industrial Belt Drives Market Records a CAGR of 3.89% Growth of Industrial Machinery in Developing Countries to Drive Market|17000+ Technavio Reports
Published: 2021-10-07 (Crawled : 12:15) - prnewswire.com
TTFNF | News | $72.26 -3.76% 1.9K |

Energy Minerals

| 44.75% | O: 0.4% H: 0.0% C: -3.79%
growth trial

---

Industrial Heat Pumps Market to grow at a CAGR of 5.33% | Evolving Opportunities with Daikin Industries Ltd. and Emerson Electric Co. | 17000 + Technavio Reports
Published: 2021-10-07 (Crawled : 10:00) - prnewswire.com
DKILF | $123.75 25.48% 1.4K |

Producer Manufacturing

| -38.32% | O: 5.45% H: 0.21% C: 0.11%
DKILY | $12.515 -0.07% 760K |

Manufacturing

| -38.27% | O: 2.53% H: 0.0% C: -0.51%
JCI | News | $63.66 -0.17% 0.0% 5.2M |

Producer Manufacturing

| -7.96% | O: 0.85% H: 1.45% C: 0.31%
trial

---

Endometrial Ablation Market Size Worth $5.4 Billion By 2028: Grand View Research, Inc.
Published: 2021-10-07 (Crawled : 10:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.36% | O: 0.07% H: 1.62% C: 0.82%
HOLX | $75.37 0.36% 0.36% 1.3M |

Health Technology

| 5.02% | O: 0.29% H: 1.33% C: 0.24%
research trial

---

USD 2.42 bn growth in the Industrial Automation Market in Life Sciences Industry|17000 + Technavio Reports
Published: 2021-10-07 (Crawled : 09:00) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K |

Producer Manufacturing

| 35.0% | O: 2.76% H: 0.12% C: -5.66%
HON | News M | $194.27 1.67% 1.64% 3.6M |

Producer Manufacturing

| -12.12% | O: 0.53% H: 0.85% C: 0.17%
ABB | News | $37.13 -0.03% 6.4M |

Producer Manufacturing

| 13.2% | O: 1.16% H: 0.75% C: 0.09%
life science growth trial

---

Industrial Enclosures Market to Witness a CAGR of 4.88% | Analysing Growth in Electrical Components & Equipment Industry |17000 + Technavio Reports
Published: 2021-10-07 (Crawled : 08:00) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K |

Producer Manufacturing

| 35.0% | O: 2.76% H: 0.12% C: -5.66%
NVT | $71.63 0.13% -0.68% 1.8M |

Electronic Technology

| 126.69% | O: 0.69% H: 2.11% C: 0.47%
HUBB | $388.03 -1.08% 0.0% 350K |

Producer Manufacturing

| 112.51% | O: 0.75% H: 1.14% C: -0.8%
ABB | News | $37.13 -0.03% 6.4M |

Producer Manufacturing

| 13.2% | O: 1.16% H: 0.75% C: 0.09%
growth trial

---

Rexlemestrocel-L Phase 3 Trial Results in Chronic Heart Failure Selected as Late Breaking Presentation at American Heart Association Annual Meeting
Published: 2021-10-07 (Crawled : 01:00) - globenewswire.com
MESO | $5.19 1.57% 1.54% 230K |

Health Technology

| -7.93% | O: 1.8% H: 1.59% C: -0.18%
presentation heart results phase 3 trial trial results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K |

Manufacturing

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---